2022
DOI: 10.1111/1756-185x.14513
|View full text |Cite
|
Sign up to set email alerts
|

SAPHO syndrome can cause masseter muscle involvement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 2 publications
0
5
0
Order By: Relevance
“…However, the persistence of symptoms prompted a crucial decision to initiate intravenous infliximab infusions at a dosage of 5 mg/kg at specified intervals. 20,21 The response of the patient to infliximab in this case report was both unique and remarkable. Within the first week of infliximab treatment, the patient experienced a dramatic improvement in neck pain.…”
Section: Discussionmentioning
confidence: 74%
See 1 more Smart Citation
“…However, the persistence of symptoms prompted a crucial decision to initiate intravenous infliximab infusions at a dosage of 5 mg/kg at specified intervals. 20,21 The response of the patient to infliximab in this case report was both unique and remarkable. Within the first week of infliximab treatment, the patient experienced a dramatic improvement in neck pain.…”
Section: Discussionmentioning
confidence: 74%
“…Partial relief was achieved through the administration of meloxicam, an NSAID, and sustained‐release diclofenac sodium capsules. However, the persistence of symptoms prompted a crucial decision to initiate intravenous infliximab infusions at a dosage of 5 mg/kg at specified intervals 20,21 …”
Section: Discussionmentioning
confidence: 99%
“…Moreover, prevalence of muscle fatty infiltration in SAPHO patients was significantly higher than that in control individuals (30.4% vs. 2.2%, p < .01). Interestingly, a recent study also showed the masseter muscle involvement in SAPHO patients 23 …”
Section: Extracutaneous/osteoarticular Manifestationsmentioning
confidence: 94%
“…30 A recent study reported masseter muscle involvement in patients with SAPHO syndrome. 31 The precise mechanism underlying sarcopenia in SAPHO syndrome remains elusive. Chronic inflammation is a risk factor for sarcopenia, which may be related to the reason that elevated cytokine levels can reduce muscle mass and function.…”
Section: Sarcopeniamentioning
confidence: 99%
“…In a study encompassing 23 SAPHO syndrome patients and 46 controls, the prevalence of fatty infiltration of muscle was significantly higher in SAPHO syndrome patients than in controls 30 . A recent study reported masseter muscle involvement in patients with SAPHO syndrome 31 . The precise mechanism underlying sarcopenia in SAPHO syndrome remains elusive.…”
Section: Extra‐articular and Cutaneous Manifestationsmentioning
confidence: 99%